SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Long Term Provisions | ₹12 Cr | ₹7.68 Cr | ₹6.05 Cr | ₹8.14 Cr |
What is the latest Long Term Provisions ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹12 Cr |
| Mar2025 | ₹7.68 Cr |
| Mar2024 | ₹6.05 Cr |
| Mar2023 | ₹8.14 Cr |
How is Long Term Provisions of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹12 Cr | 60.70 | |
| Mar2025 | ₹7.68 Cr | 26.92 | |
| Mar2024 | ₹6.05 Cr | -25.68 | |
| Mar2023 | ₹8.14 Cr | - | |
Compare Long Term Provisions of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹6,613.3 Cr | 5% | 4.9% | 43.1% | Stock Analytics | |
| PRIME FOCUS | ₹24,823.4 Cr | -7.5% | 5.4% | 77.7% | Stock Analytics | |
| SAGILITY | ₹21,019.2 Cr | -1.6% | 4.3% | -1.1% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹15,355.6 Cr | 3% | -6.4% | -42% | Stock Analytics | |
| INDEGENE | ₹14,300.2 Cr | -0.7% | 5.3% | 2.1% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹14,045.2 Cr | -1.8% | -5.5% | -12.2% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 5% |
4.9% |
43.1% |
| SENSEX | -1% |
-4.9% |
-11% |
You may also like the below Video Courses